← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nature Technology Corporation
Lincoln, NE
$3,037,527
Total funding
8
Grants
Funding over time
peak $765.9K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,037,527 · 8
By mechanism
R44$2,015,023 · 2
R43$1,022,504 · 6
Investigators at Nature Technology Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
eukaryotic expression vectors resistant to transgene silencing$580,193
R44 · FY2011 · GM
eukaryotic expression vectors resistant to transgene silencing$524,606
R44 · FY2012 · GM
Chimeric enzyme for nucleic acid autohydrolysis$496,886
R44 · FY2006 · GM
Chimeric enzyme for nucleic acid autohydrolysis$413,338
R44 · FY2007 · GM
MiniPlasmid vector platform for non-viral gene therapy$247,934
R43 · FY2013 · GM
Rapid deployment DNA vaccine for pandemic influenza$207,016
R43 · FY2007 · AI
eukaryotic expression vectors resistant to transgene silencing$145,542
R43 · FY2007 · GM
Chimeric enzyme for host nucleic acid autohydrolysis$143,800
R43 · FY2004 · GM
Promoter Rescue Vectors$142,017
R43 · FY2003 · GM
Antisense inhibitors for enhanced plasmid production$136,195
R43 · FY2005 · GM